Board of Advisors
Dr. Karin Jorga, Ph.D., has over 20 years of experience in drug development of small and large molecules across all therapeutic areas. She has an extensive scientific background in clinical pharmacology, with expertise in leveraging biomarkers and applying computer models to address drug development challenges and support data-driven decision-making.
Dr. Jorga’s past experience includes being the global head of biomarker technology and science, global head of clinical pharmacology, and global head of modeling and simulation at Roche.
She currently runs a consulting firm, KarinJorga Life Science Consulting, that was founded in 2014 in Basel with the ambition to develop scientific innovations into medicines for tomorrow.
